Motilal Oswal is optimistic about Mankind Pharma and has given a buy rating on the stock, setting a target price of Rs 3140 in its research report dated November 5, 2024.
Purchase Mankind Pharma; target price of Rs 3140: Motilal Oswal
Financial future with knowledge and awareness